Elizabeth R. Packnett, Isabelle H. Winer, Heather Larkin, Abiola Oladapo, Tara Gonzales, Matthew Wojdyla, . . . Vincent C. Smith. (2022). RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020. Taylor & Francis Group.
Chicago Style (17th ed.) CitationElizabeth R. Packnett, Isabelle H. Winer, Heather Larkin, Abiola Oladapo, Tara Gonzales, Matthew Wojdyla, Mitchell Goldstein, and Vincent C. Smith. RSV-related Hospitalization and Outpatient Palivizumab Use in Very Preterm (born at <29 WGA) Infants: 2003-2020. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationElizabeth R. Packnett, et al. RSV-related Hospitalization and Outpatient Palivizumab Use in Very Preterm (born at <29 WGA) Infants: 2003-2020. Taylor & Francis Group, 2022.